Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Lymphoma, Follicular 2Lymphoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Radiotherapy 3Cisplatin 2sapropterin 1pembrolizumab 1fludarabine 1Watchful Waiting 1Surgical Procedures, Operative 1Sentinel Lymph Node Biopsy 1Ritonavir 1Radiotherapy, Intensity-Modulated 1Platinum 1Mindfulness 1Indinavir 1Gene Rearrangement 1Gene Expression Profiling 1Gemcitabine 1Exercise 1Electrochemotherapy 1Drug Therapy 1Cyclophosphamide 1Bleomycin 1Amplified Fragment Length Polymorphism Analysis 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vulvar Neoplasms × Gene Rearrangement × Clear all
NCT00601406 2013-08-26

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

National Cancer Institute (NCI)

Phase NA Unknown
2,200 enrolled
BreastGenitourinaryGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡